Subscribe
← Back to Pharma / Biotech Companies

DualityBio

映恩生物

📍 Shanghai Founded 2019
Biotech, ADC, Antibody-Drug Conjugate
Next-gen ADC (antibody-drug conjugate) platform. Multiple ADC candidates in clinical trials. Partnership with BioNTech for $1.5B+.
Valuation
$2B (2024)
Employees
500+
Headquarters
Shanghai
Website
www.dualitybio.com
Stock
Private Company
Founded
2019

Pharma / Biotech Companies